In the UK, approximately 10 500 people have cystic fibrosis (CF), one of the most common life-threatening genetic diseases.1 In recent years, precision medicines called CF transmembrane conductance regulator (CFTR) modulators have been developed to treat people with CF (pwCF). Here, CFTR is linked to cystic fibrosis.